Wound healing
Conditions
Interventions
Intervention 1: The patients were randomized by concealed allocation to one of two groups: Alkanna tinctoria cream (group A [n = 30]), placebo cream (base cream without Alkanna tinctoria extract, grou
Treatment - Drugs
The patients were randomized by concealed allocation to one of two groups: Alkanna tinctoria cream (group A [n = 30]), placebo cream (base cream without Alkanna tinctoria extract, group B [n = 30]) th
the control group received daily topical application of placebo ointment. According to the protocol, the donor site dressing was changed daily. At the days 14 and 28 after applying dressing, the perce
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 60 Years
Inclusion criteria
Inclusion criteria: • Entrance criteria:patients need to Split-thickness skin Graft Donor • Exclusion criteria: diabet ;hypo proteinemia (alb60 ;Use of drugs that induced P450 activation; Pregnancy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound healling. Timepoint: 0-2-4 week. Method of measurement: Wound Assessment Tools. | — |
Secondary
| Measure | Time frame |
|---|---|
| Wound Exudate. Timepoint: 0-2-4 week. Method of measurement: observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr GhasemAli Khorasani
Tehran University of Medical Sciences
Outcome results
None listed